Genesis HealthCare System Builds on its Investment in BIO-key Biometric Authentication Security as it Migrates to Epic Hyperdrive

ZANESVILLE, Ohio and HOLMDEL, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that its longstanding customer Genesis HealthCare System, the largest healthcare provider in its six-county region of Ohio, will add BIO-key’s PortalGuard IAM platform to support its existing BIO-key biometric authentication investment as it migrates to Epic Systems’ Hyperdrive end-user application interface. Genesis HealthCare has a network of more than 300 physicians and 4,000 employees across 27 locations.

PortalGuard’s standards-based integration with Hyperdrive allows Genesis HealthCare System to continue enjoying the security and streamlined biometric authentication user experience that BIO-key provides without re-enrolling employees or adopting more cumbersome and expensive multi-factor authentication solutions.

Named by Computerworld as one of the 100 Best Places to Work in IT every year since 2017, Genesis Healthcare utilizes BIO-key biometric software and hardware to secure and streamline its users’ login experience for Epic. By deploying PortalGuard IAM, it is able to maintain a consistent user experience and simplify the Hyperdrive migration. PortalGuard fully supports Hyperdrive’s modern authentication approach through its SAML Identity Provider (IdP) capabilities. PortalGuard provides seventeen authentication factor options, including WEB-key fingerprint authentication, the same core BIO-key biometric authentication platform regularly used by thousands of Genesis HealthCare employees. Additionally, users can now use PortalGuard for biometric authentication in other hospital applications through its support for standard IdP integration options like SAML, OAUTH, and OpenID Connect.

"Epic is a mission-critical application for many of BIO-key’s hospital customers, and implementing PortalGuard SAML SSO allows Genesis to maintain streamlined workflows and ensure secure access to patient information with IBB," said Mark Cochran, President of BIO-key – PortalGuard. "Healthcare organizations face the challenge of providing convenient and reliable access to necessary systems while ensuring data privacy and regulatory compliance. BIO-key’s Identity-Bound Biometrics allows customers to cost-effectively leverage a phoneless, tokenless, and cardless authentication experience that users prefer because it strikes the proper balance between security and convenience."

About BIO-key International, Inc. (
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

Engage with BIO-key

Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Investor Contacts

William Jones, David Collins
Catalyst IR or 212-924-9800